Showing results (61-70 of 166) with videos related to
Sort By:
Pageof 17
BMJ (Clinical Research Ed.)|March 23, 2004
Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysisDavid C Mohr, Stacey L Hart, Laura Julian, et al.Psychosomatic Medicine|December 1, 2012
Prospective examination of anxiety and depression before and during confirmed and pseudoexacerbations in patients with multiple sclerosisMichelle Nicole Burns, Ewa Nawacki, Juned Siddique, et al.Magnetic Resonance Imaging|August 22, 2009
MR spectroscopic imaging of glutathione in the white and gray matter at 7 T with an application to multiple sclerosisRadhika Srinivasan, Helene Ratiney, Kathyrn E Hammond-Rosenbluth, et al.Journal of the Neurological Sciences|June 12, 2016
Subcortical grey matter volumes predict subsequent walking function in early multiple sclerosisBardia Nourbakhsh, Christina Azevedo, Amir-Hadi Maghzi, et al.Journal of Magnetic Resonance Imaging : JMRI|June 29, 2016
Reproducibility measurement of glutathione, GABA, and glutamate: Towards in vivo neurochemical profiling of multiple sclerosis with MR spectroscopy at 7THetty Prinsen, Robin A de Graaf, Graeme F Mason, et al.Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|April 20, 2007
Multislice brain myelin water fractions at 3T in multiple sclerosisJoonmi Oh, Eric T Han, Michael C Lee, et al.Neuroimage|January 25, 2006
TE-averaged two-dimensional proton spectroscopic imaging of glutamate at 3 TRadhika Srinivasan, Charles Cunningham, Albert Chen, et al.Journal of the Neurological Sciences|April 28, 2009
Connecting white matter injury and thalamic atrophy in clinically isolated syndromesRoland G Henry, Mason Shieh, Bagrat Amirbekian, et al.Magnetic Resonance in Medicine|March 9, 2004
Measurement of brain glutamate using TE-averaged PRESS at 3TRalph Hurd, Napapon Sailasuta, Radhika Srinivasan, et al.The New England Journal of Medicine|June 11, 2005
Progressive multifocal leukoencephalopathy in a patient treated with natalizumabAnnette Langer-Gould, Scott W Atlas, Ari J Green, et al.Pageof 17